Support Programs

Information, reminders, and financial support for parents like you

The Cradle With Care program provides information about your baby’s health for the RSV season

Cradle with CareSM

The Cradle with Care program is designed to help you and your baby throughout the RSV season. By enrolling, you will receive a welcome kit in the mail providing an overview of the program. In addition, Cradle with Care will send you useful tools and resources, such as: important reminders, educational information about your baby’s health, and information about financial and insurance matters.

SIGN UP TODAY

 

Jessica’s story: A mom who benefited from Cradle with CareSM

Listen to Jessica’s story: A mom who benefited from the Cradle with Care program Listen to Jessica’s story: A mom who benefited from the Cradle with Care program
Access 360 is the patient savings program from SYNAGIS.

Patient savings program

Access 360TM is the patient savings program from SYNAGIS. Qualified patients on SYNAGIS may receive up to $2000 to help with out-of-pocket costs for SYNAGIS. Patients are responsible for the first $30 of each dose of SYNAGIS. There are no income requirements to participate in the program. Eligibility rules and restrictions apply.

LEARN MORE

Find out about Co-pay Savings for SYNAGIS

saving card

IMPORTANT SAFETY INFORMATION

open isi

Who should not receive SYNAGIS?

Children should not receive SYNAGIS if they have ever had a severe allergic reaction to it. Signs and symptoms of a severe allergic reaction could include itchy rash; swelling of the face; difficulty swallowing; difficulty breathing; bluish color of the skin; muscle weakness or floppiness; and/or unresponsiveness. If your child has any of these signs or symptoms of a severe allergic reaction after getting SYNAGIS, call your child’s healthcare provider or get medical help right away.

IMPORTANT SAFETY INFORMATION

Who should not receive SYNAGIS?

Children should not receive SYNAGIS if they have ever had a severe allergic reaction to it. Signs and symptoms of a severe allergic reaction could include itchy rash; swelling of the face; difficulty swallowing; difficulty breathing; bluish color of the skin; muscle weakness or floppiness; and/or unresponsiveness. If your child has any of these signs or symptoms of a severe allergic reaction after getting SYNAGIS, call your child’s healthcare provider or get medical help right away.

How is SYNAGIS given?

SYNAGIS is given as a monthly injection, usually in the thigh (leg) muscle, by your child’s healthcare provider. If your child has a problem with bleeding or bruises easily, an injection could cause a problem. Your child should receive their first injection of SYNAGIS before the RSV season starts, to help protect them before RSV becomes active. RSV season is usually fall through spring, but it may begin earlier or last longer in certain areas. When RSV is most active, your child will need to receive injections of SYNAGIS every 28-30 days to help protect them from severe RSV disease for about a month. Your child should continue to receive monthly injections of SYNAGIS until the end of RSV season. Your child may still get severe RSV disease after receiving SYNAGIS. If your child has an RSV infection, they should continue to get their monthly injections throughout the RSV season to help prevent severe disease from new RSV infections.

The effectiveness of injections of SYNAGIS given less than monthly throughout the RSV season has not been established.

What are the possible side effects of SYNAGIS?

Serious side effects include severe allergic reactions, which may happen after any injection of SYNAGIS and may be life-threatening or cause death. Call your child’s healthcare provider or get medical help right away if your child has any of the signs or symptoms of a serious allergic reaction. See “Who should not receive SYNAGIS?” for more information.

Common side effects of SYNAGIS include fever and rash.

These are not all the possible side effects of SYNAGIS.

APPROVED USE

SYNAGIS is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children:

  • born prematurely (at or before 35 weeks) and who are 6 months of age or less at the beginning of RSV season
  • who have a chronic lung condition called bronchopulmonary dysplasia (BPD), that needed medical treatment within the last 6 months, and who are 24 months of age or less at the beginning of RSV season
  • born with certain types of heart disease and who are 24 months of age or less at the beginning of RSV season

It is not known if SYNAGIS is safe and effective:

  • to treat the symptoms of RSV in a child who already has RSV. SYNAGIS is used to help prevent RSV disease
  • in children who are older than 24 months of age at the start of dosing

Please see full Prescribing Information for SYNAGIS, including Patient Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

backtotop
 
 

Contact Us X

Looking for more information? We're happy to help you with any concerns or questions you may have about SYNAGIS® (palivizumab) or severe RSV disease.

MedImmune Customer Support Network

Call toll-free: 1-877-633-4411

Hours of operation: Monday—Friday, 8:00 AM6:00 PM ET